LENORA DEBORD: Open Payments
NPI 1801189261 · SOMERSET, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 14 payments from 6 companies in 2025. Trend: 2023 $174 · 2024 $171 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $93 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| Alkermes, Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
Products named: REXULTI, COBENFY, VRAYLAR, FANAPT, UZEDY, ARISTADA, LYBALVI, ABILIFY MAINTENA.
Industry payments across KY — which companies pay providers there.
